Comparison of Clinical Outcomes Between Left Bundle Branch Area Pacing With a Stylet‐Driven Lead and Conventional Right Ventricular Pacing

Kyung‐Yeon Lee, Jinsun Park, JungMin Choi, Hyo‐Jeong Ahn, Soonil Kwon, Jun Kim, Gi‐Byoung Nam, Kee‐Joon Choi, Eue‐Keun Choi, Seil Oh, Min Soo Cho, So‐Ryoung LeeJournal of Cardiovascular Electrophysiology 2025 · DOI

TL;DR

This study compares Left Bundle Branch Area Pacing (LBBAP) using stylet-driven leads (SDL) against conventional Right Ventricular Pacing (RVP) in patients needing significant ventricular pacing. LBBAP with SDL demonstrated a significantly lower risk of adverse clinical outcomes, including heart failure hospitalizations and pacing-induced cardiomyopathy, while maintaining similar safety profiles to RVP.

What Problem Does This Paper Address?

For patients requiring pacemakers, particularly those with a high burden of ventricular pacing, conventional Right Ventricular Pacing (RVP) can lead to left ventricular dyssynchrony and pacing-induced cardiomyopathy (PICM). Conduction system pacing (CSP), including Left Bundle Branch Area Pacing (LBBAP), has emerged as a promising alternative to preserve physiological ventricular activation and mitigate these adverse effects. While LBBAP has shown benefits, most comparative studies have used lumenless leads (LLL). This paper addresses the gap in understanding the clinical outcomes of LBBAP specifically when using stylet-driven leads (SDL), which are more commonly available in some regions, compared to conventional RVP. The study aims to determine if LBBAP with SDL offers comparable or superior clinical outcomes to RVP.

Methods

This was a retrospective observational cohort study conducted at two tertiary hospitals. Patients who underwent pacemaker implantation between December 2018 and December 2023 were included. Patients requiring cardiac resynchronization therapy (CRT) or those with a ventricular pacing burden of less than 10% during follow-up were excluded. LBBAP was performed using a stylet-driven lead (Solia S60, Biotronik) with a fixed curve delivery sheath.

The study defined two composite outcomes:

  • Composite Outcome I: Heart failure (HF) admission, pacing-induced cardiomyopathy (PICM), or upgrade to biventricular pacing.
  • Composite Outcome II: All-cause death in addition to the components of Composite Outcome I.

PICM was defined as a decline in left ventricular ejection fraction (LVEF) to below 50% or a decrease of more than 10% from baseline. Statistical analysis involved comparing baseline characteristics using t-tests and chi-squared tests. Incidence rates were calculated per 100 person-years, and survival analysis was performed using Kaplan-Meier curves and Cox proportional hazard regression to determine hazard ratios (HRs) with 95% confidence intervals (CIs). Multivariable models were used to adjust for potential confounders.

Datasets

The study utilized data from 738 patients who underwent pacemaker implantation at Seoul National University Hospital and Asan Medical Center. This retrospective dataset was collected between December 2018 and December 2023. No new datasets or benchmarks were introduced.

Key Insights and Ideas

  • LBBAP with SDL is a viable and effective alternative: The study demonstrates that LBBAP can be safely and effectively performed using stylet-driven leads, challenging the notion that only lumenless leads are suitable for this advanced pacing technique.
  • Significant reduction in adverse cardiac events: The most striking finding is the substantial reduction in the risk of composite adverse outcomes (PICM, HF hospitalization, CRT upgrade, and death) for patients receiving LBBAP with SDL compared to RVP, even with a higher ventricular pacing burden.
  • PICM is the primary driver of benefit: The reduced risk of pacing-induced cardiomyopathy appears to be the main contributor to the improved composite outcomes observed with LBBAP. This highlights the importance of preserving physiological conduction to prevent cardiac remodeling.
  • Similar safety profiles: Despite the different lead technologies and pacing sites, the study found no significant differences in procedure-related complications between LBBAP with SDL and RVP, suggesting comparable safety.

Key Results

  • A total of 738 patients were included: 495 in the RVP group and 243 in the LBBAP group.
  • LBBAP was associated with a significantly lower risk of Composite Outcome I (adjusted HR 0.27; 95% CI 0.11-0.68, p=0.006) and Composite Outcome II (adjusted HR 0.41; 95% CI 0.20-0.84, p=0.015) compared to RVP.
  • The risk of pacing-induced cardiomyopathy (PICM) was reduced by 70% in the LBBAP group compared to the RVP group (adjusted HR 0.30; 95% CI 0.11-0.86, p=0.025).
  • The LBBAP group had a higher ventricular pacing burden (95.5% vs. 86.3%, p<0.001) but still showed better outcomes.
  • There were no significant differences in acute or chronic procedure-related complications between the groups.

Limitations and Future Work

The authors acknowledge several limitations:

  • Observational nature: The study design makes it impossible to infer causality.
  • Small patient numbers: While 738 patients is a substantial cohort, larger, multicenter, randomized controlled trials are needed for broader generalization.
  • Differential follow-up duration: The LBBAP group had a shorter median follow-up (371 days) compared to the RVP group (776 days) due to the later adoption of LBBAP. Longer-term data is crucial.
  • Soft endpoint: The primary outcome included PICM, which is based on echocardiographic findings, potentially affecting robustness.
  • Retrospective design: Inherent differences between groups may introduce residual confounding, despite statistical adjustments.
  • Acute success rate: The study primarily reports acute success rates, with limited long-term pacing data.
  • Capture area: The study did not analyze how the LBB area capture was maintained over time, which could influence outcomes.

Future work should focus on larger randomized controlled trials to confirm these findings and investigate the long-term performance of LBBAP with SDL, including the stability of LBB capture and its impact on patient outcomes. Further research is also needed to compare different lead types for LBBAP and to understand the nuances of pacing in specific patient populations.

Summary updated

Abstract

LBBAP with SDL was associated with a lower risk of adverse clinical outcomes compared to conventional RVP in patients requiring substantial ventricular pacing.
BibTeX
@article{lee2025comparison,
  author = {Kyung‐Yeon Lee and Jinsun Park and JungMin Choi and Hyo‐Jeong Ahn and Soonil Kwon and Jinsun Park and Jun Kim and Gi‐Byoung Nam and Kee‐Joon Choi and Eue‐Keun Choi and Seil Oh and Min Soo Cho and So‐Ryoung Lee},
  title = {{Comparison of Clinical Outcomes Between Left Bundle Branch Area Pacing With a Stylet‐Driven Lead and Conventional Right Ventricular Pacing}},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  doi = {10.1111/jce.16648},
}
Figure